BIGBEAR
PHARMACEUTICALS
Anagrelide is an oral thrombocytopenic agent that belongs to the class of phosphodiesterase 3 (PDE3) inhibitors.
AuthenticGuaranteeFast DeliveryPrivacy Anagrelide requires close monitoring of its potential side effects, methods of relief, and proper storage to ensure therapeutic efficacy and minimize ···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 71
Anagrelide, a thrombocytopenic drug, plays an important role in the treatment of certain hematological diseases. Its clinical application requires str···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 71
In addition to its expected therapeutic effects, selumetinib may cause some adverse reactions. While not all side effects will occur, medical interven···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 71
Anagrelide is a platelet-reducing agent, also known as a platelet production inhibitor. Domestically produced Anagrelide capsules were launched in Chi···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 71
Anagrelide is a selective platelet-producing inhibitor, approved for marketing in the United States in 1997, and subsequently approved in Europe and o···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 71
Anagrelide is primarily used to treat thrombocytosis, especially essential thrombocytosis, reducing the risk of thrombosis and improving patients'···【Read More】
Update: 04 Mar,2026Source: Haiou HealthViews: 71
Drug Interactions1.Concomitant use of this product with drugs that prolong the QT interval is prohibited (including but not limited to: clarithromycin···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 70
Anagrelide is used for the treatment of thrombocytosis associated with essential thrombocythemia and polycythemia vera. It may also be used for thromb···【Read More】
Update: 27 Feb,2026Source: Haiou HealthViews: 69
Copyright2024@ BIGBEAR All right reserved BIGBEAR
